SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-011441
Filing Date
2016-01-11
Accepted
2016-01-11 06:07:17
Documents
2
Period of Report
2016-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1598
2 EX-24 DOCUMENT attachment1.htm EX-24 4031
  Complete submission text file 0000899243-16-011441.txt   7108
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Szela Mary T (Reporting) CIK: 0001410289 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34921 | Film No.: 161334909